Rufinamide

FDA Approved: * May 16, 2016
Pharm Company: * ROXANE
Category: Anticonvulsant

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Rufinamide Overview

Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome[2] and various other seizure disorders. Rufinamide, a triazole derivative, was developed in 2004 by Novartis Pharma, AG, and is manufactured by Eisai. Rufinamide was approved by the US Food and Drug Administration (FDA) on November 14, 2008, as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children four ye...

Read more Rufinamide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Rufinamide

Recent Rufinamide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Rufinamide: (3 results)

Sorted by National Drug Code

• 0054-0528 Rufinamide 40 mg/ml Oral Suspension by Hikma Pharmaceuticals USA Inc.
• 67877-673 Rufinamide 40 mg/ml Oral Suspension by Ascend Laboratories, LLC
• 69452-223 Rufinamide 40 mg/ml Oral Suspension by Bionpharma Inc.

Other drugs which contain Rufinamide or a similar ingredient: (1 result)

• BANZEL Rufinamide1 discussion